GeneXpert test cartridge being used to test a sample of suspected TB in MSF’s lab at Bangassou Hospital, Central African Republic, 2017.
Press release |

Cepheid and Danaher have just announced that they are reducing the price of the Xpert MTB/RIF test by 20% in high-TB-burden countries, from US$9.98 to $7.97 per test. This reduction is a significant step, considering the corporations have refused to reduce the price of this test for over ten years.

Read more
Photo credit: Borja Ruiz Rodriguez/MSF

Latest news

What good is a breakthrough medicine if the people who need it can't afford it?